Group 1 - The core point of the article is that Shangtai Technology announced a share reduction by board member Qi Zhonghui and supervisor Sun Yujie, totaling 340,000 shares, which represents 0.1309% of the company's total shares [1] - As of the report, Shangtai Technology has a market capitalization of 22.4 billion yuan [1] - For the first half of 2025, the revenue composition of Shangtai Technology is as follows: lithium-ion battery anode materials account for 91.57%, carbon products account for 4.81%, and other businesses account for 3.62% [1]

截至发稿，华东医药市值为708亿元。 每经头条（nbdtoutiao）——展望"十五五" | 专访黄群慧：既要重视AI赋能千行百业，也要考量其对就业 的替代效应和带来的收入极化 （记者 王晓波） 每经AI快讯，华东医药（SZ 000963，收盘价：40.36元）11月21日晚间发布公告称，公司第十一届第五 次董事会会议于2025年11月20日在公司会议室以现场并结合通讯方式召开。会议审议了《关于召开2025 年第二次临时股东会的议案》等文件。 2025年1至6月份，华东医药的营业收入构成为：商业经纪与代理业占比68.23%，医药制造占比 33.94%，医美占比4.57%，其他业务占比0.77%，分部间抵销占比-7.5%。 ...

Group 1 - The actual controller of Weihai Guangtai, Mr. Li Guangtai, plans to reduce his holdings by up to approximately 10.41 million shares, which is no more than 2% of the company's total share capital after deducting repurchased shares, within three months from December 15, 2025, to March 14, 2026 [1] - For the first half of 2025, Weihai Guangtai's revenue composition shows that the equipment manufacturing industry accounts for 99.92%, while other industries account for 0.08% [1] - As of the report date, Weihai Guangtai has a market capitalization of 5.3 billion yuan [1]

Group 1 - The core point of the article is that Huatai (SZ 001217) held its sixth session of the eighth board meeting on November 21, 2025, to discuss organizational adjustments [1] - For the first half of 2025, Huatai's revenue composition was 79.17% from basic chemicals and 20.83% from fine chemicals [1] - As of the report date, Huatai's market capitalization was 4.4 billion yuan [1]

截至发稿，联芸科技市值为213亿元。 每经头条（nbdtoutiao）——展望"十五五" | 专访黄群慧：既要重视AI赋能千行百业，也要考量其对就业 的替代效应和带来的收入极化 2024年1至12月份，联芸科技的营业收入构成为：集成电路占比99.77%，其他业务占比0.23%。 （记者 曾健辉） 每经AI快讯，联芸科技（SH 688449，收盘价：46.35元）11月21日晚间发布公告称，公司限售股份约 2.23亿股将于2025年12月1日解禁并上市流通，占公司总股本比例为48.52%。 ...

Group 1 - The company, Aerospace Electric (SZ 002025), announced the convening of its 12th temporary board meeting for 2025 on November 21, 2025, to discuss the reappointment of the auditing firm, ShineWing Certified Public Accountants [1] - For the first half of 2025, the company's revenue composition was 98.21% from the electronic components industry and 1.79% from other businesses [1] - As of the report date, the market capitalization of Aerospace Electric was 18.9 billion yuan [1]

截至发稿，天融信市值为104亿元。 每经头条（nbdtoutiao）——展望"十五五" | 专访黄群慧：既要重视AI赋能千行百业，也要考量其对就业 的替代效应和带来的收入极化 每经AI快讯，天融信（SZ 002212，收盘价：8.83元）11月21日晚间发布公告称，公司第七届第二十八 次董事会会议于2025年11月21日以通讯表决方式召开。会议审议了《关于制定部分公司治理制度的议 案》等文件。 2025年1至6月份，天融信的营业收入构成为：网络安全占比99.37%，其他业务占比0.63%。 （记者 曾健辉） ...

截至发稿，冀中能源市值为210亿元。 每经头条（nbdtoutiao）——展望"十五五" | 专访黄群慧：既要重视AI赋能千行百业，也要考量其对就业 的替代效应和带来的收入极化 （记者 曾健辉） 每经AI快讯，冀中能源（SZ 000937，收盘价：5.94元）11月21日晚间发布公告称，公司第八届第十九 次董事会会议于2025年11月21日在公司金牛大酒店四层第二会议厅召开。会议审议了《关于修订、制定 公司部分治理制度的议案》等文件。 2025年1至6月份，冀中能源的营业收入构成为：煤炭采选业占比78.34%，化工行业占比14.09%，建材 行业占比7.08%，电力行业占比0.35%，其他行业占比0.14%。 ...

（记者 张明双） 截至发稿，全志科技市值为329亿元。 每经头条（nbdtoutiao）——展望"十五五" | 专访黄群慧：既要重视AI赋能千行百业，也要考量其对就业 的替代效应和带来的收入极化 每经AI快讯，全志科技（SZ 300458，收盘价：39.91元）11月21日晚间发布公告称，公司第五届第二十 次董事会会议于2025年11月21日在公司二楼会议室以现场表决与通讯表决相结合的方式召开。会议审议 了《关于修订 <董事会审计委员会工作条例> 的议案》等文件。 2024年1至12月份，全志科技的营业收入构成为：集成电路设计占比99.98%，房租占比0.02%。 ...

Group 1 - The company, Maipu Medical, announced plans to sign lease agreements with related parties, Guangzhou Yijie Medical Technology Co., Ltd. and Guangzhou Jianwei Medical Technology Co., Ltd. [1] - The lease with Yijie Medical involves a property in Guangzhou with a total area of 2501.11 square meters, intended for office and R&D purposes, with a rental period from January 1, 2026, to December 31, 2028 [1] - The monthly rent is set at 65 yuan per square meter (including tax), with a total rental amount of approximately 5.85 million yuan and property management fees totaling about 1.17 million yuan, leading to a combined total of approximately 7.02 million yuan [1] Group 2 - For the year 2024, Maipu Medical's revenue composition is projected to be 97.51% from implantable medical devices and 2.49% from other sources [1] - As of the report date, Maipu Medical has a market capitalization of 4.2 billion yuan [1]